nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Tamoxifen—pancreatic cancer	0.142	0.202	CbGbCtD
Levetiracetam—ABCC2—Irinotecan—pancreatic cancer	0.109	0.155	CbGbCtD
Levetiracetam—ABCC2—Docetaxel—pancreatic cancer	0.0799	0.114	CbGbCtD
Levetiracetam—ABCC2—Sunitinib—pancreatic cancer	0.0795	0.113	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—pancreatic cancer	0.0595	0.0848	CbGbCtD
Levetiracetam—ABCB1—Tamoxifen—pancreatic cancer	0.0463	0.0659	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—pancreatic cancer	0.0399	0.0568	CbGbCtD
Levetiracetam—ABCB1—Erlotinib—pancreatic cancer	0.0393	0.056	CbGbCtD
Levetiracetam—ABCB1—Irinotecan—pancreatic cancer	0.0355	0.0506	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—pancreatic cancer	0.026	0.0371	CbGbCtD
Levetiracetam—ABCB1—Sunitinib—pancreatic cancer	0.0259	0.0369	CbGbCtD
Levetiracetam—ABCC2—bile duct—pancreatic cancer	0.0198	0.386	CbGeAlD
Levetiracetam—ABCB1—Doxorubicin—pancreatic cancer	0.0194	0.0276	CbGbCtD
Levetiracetam—ABCC2—bile—pancreatic cancer	0.0152	0.296	CbGeAlD
Levetiracetam—SV2A—islet of Langerhans—pancreatic cancer	0.0124	0.241	CbGeAlD
Levetiracetam—ABCC2—digestive system—pancreatic cancer	0.00166	0.0324	CbGeAlD
Levetiracetam—ABCB1—islet of Langerhans—pancreatic cancer	0.000996	0.0194	CbGeAlD
Levetiracetam—ABCB1—pancreas—pancreatic cancer	0.0007	0.0136	CbGeAlD
Levetiracetam—ABCB1—digestive system—pancreatic cancer	0.000598	0.0116	CbGeAlD
Levetiracetam—Dyspepsia—Fluorouracil—pancreatic cancer	0.000233	0.000947	CcSEcCtD
Levetiracetam—Nausea—Tamoxifen—pancreatic cancer	0.000233	0.000945	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000233	0.000944	CcSEcCtD
Levetiracetam—Fatigue—Gemcitabine—pancreatic cancer	0.000232	0.000943	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—pancreatic cancer	0.000231	0.000939	CcSEcCtD
Levetiracetam—Pain—Gemcitabine—pancreatic cancer	0.00023	0.000935	CcSEcCtD
Levetiracetam—Constipation—Gemcitabine—pancreatic cancer	0.00023	0.000935	CcSEcCtD
Levetiracetam—Nausea—Erlotinib—pancreatic cancer	0.00023	0.000935	CcSEcCtD
Levetiracetam—Decreased appetite—Fluorouracil—pancreatic cancer	0.00023	0.000935	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—pancreatic cancer	0.00023	0.000934	CcSEcCtD
Levetiracetam—Diarrhoea—Sunitinib—pancreatic cancer	0.00023	0.000933	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000229	0.000928	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—pancreatic cancer	0.000228	0.000927	CcSEcCtD
Levetiracetam—Feeling abnormal—Irinotecan—pancreatic cancer	0.000228	0.000925	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—pancreatic cancer	0.000227	0.000921	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—pancreatic cancer	0.000227	0.000921	CcSEcCtD
Levetiracetam—Back pain—Docetaxel—pancreatic cancer	0.000227	0.00092	CcSEcCtD
Levetiracetam—Pain—Fluorouracil—pancreatic cancer	0.000227	0.00092	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000226	0.000918	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—pancreatic cancer	0.000226	0.000916	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—pancreatic cancer	0.000225	0.000911	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000224	0.00091	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—pancreatic cancer	0.000222	0.000903	CcSEcCtD
Levetiracetam—Dizziness—Sunitinib—pancreatic cancer	0.000222	0.000901	CcSEcCtD
Levetiracetam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000222	0.000901	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000222	0.0009	CcSEcCtD
Levetiracetam—Abdominal pain—Irinotecan—pancreatic cancer	0.000219	0.000888	CcSEcCtD
Levetiracetam—Body temperature increased—Irinotecan—pancreatic cancer	0.000219	0.000888	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000219	0.000887	CcSEcCtD
Levetiracetam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000218	0.000886	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—pancreatic cancer	0.000218	0.000885	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000217	0.000881	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—pancreatic cancer	0.000215	0.000874	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—pancreatic cancer	0.000214	0.000869	CcSEcCtD
Levetiracetam—Vomiting—Sunitinib—pancreatic cancer	0.000214	0.000867	CcSEcCtD
Levetiracetam—Body temperature increased—Gemcitabine—pancreatic cancer	0.000213	0.000865	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—pancreatic cancer	0.000212	0.000861	CcSEcCtD
Levetiracetam—Rash—Sunitinib—pancreatic cancer	0.000212	0.000859	CcSEcCtD
Levetiracetam—Dermatitis—Sunitinib—pancreatic cancer	0.000212	0.000859	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000211	0.000856	CcSEcCtD
Levetiracetam—Headache—Sunitinib—pancreatic cancer	0.00021	0.000854	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—pancreatic cancer	0.00021	0.000852	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—pancreatic cancer	0.00021	0.000852	CcSEcCtD
Levetiracetam—Leukopenia—Docetaxel—pancreatic cancer	0.00021	0.000851	CcSEcCtD
Levetiracetam—Body temperature increased—Fluorouracil—pancreatic cancer	0.000209	0.00085	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—pancreatic cancer	0.000208	0.000843	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—pancreatic cancer	0.000206	0.000838	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—pancreatic cancer	0.000206	0.000835	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—pancreatic cancer	0.000205	0.000833	CcSEcCtD
Levetiracetam—Cough—Docetaxel—pancreatic cancer	0.000204	0.00083	CcSEcCtD
Levetiracetam—Hypersensitivity—Irinotecan—pancreatic cancer	0.000204	0.000827	CcSEcCtD
Levetiracetam—Convulsion—Docetaxel—pancreatic cancer	0.000203	0.000824	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—pancreatic cancer	0.000202	0.000821	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—pancreatic cancer	0.000202	0.000821	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—pancreatic cancer	0.000202	0.000821	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—pancreatic cancer	0.000202	0.000819	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.0002	0.000814	CcSEcCtD
Levetiracetam—Arthralgia—Docetaxel—pancreatic cancer	0.000199	0.00081	CcSEcCtD
Levetiracetam—Chest pain—Docetaxel—pancreatic cancer	0.000199	0.00081	CcSEcCtD
Levetiracetam—Myalgia—Docetaxel—pancreatic cancer	0.000199	0.00081	CcSEcCtD
Levetiracetam—Nausea—Sunitinib—pancreatic cancer	0.000199	0.00081	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—pancreatic cancer	0.000199	0.000809	CcSEcCtD
Levetiracetam—Asthenia—Irinotecan—pancreatic cancer	0.000198	0.000806	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000198	0.000804	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—pancreatic cancer	0.000197	0.0008	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—pancreatic cancer	0.000197	0.000798	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—pancreatic cancer	0.000197	0.000798	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—pancreatic cancer	0.000196	0.000796	CcSEcCtD
Levetiracetam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000195	0.000792	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000195	0.000792	CcSEcCtD
Levetiracetam—Asthenia—Gemcitabine—pancreatic cancer	0.000193	0.000785	CcSEcCtD
Levetiracetam—Confusional state—Docetaxel—pancreatic cancer	0.000193	0.000783	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000191	0.000776	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—pancreatic cancer	0.000191	0.000775	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—pancreatic cancer	0.000191	0.000774	CcSEcCtD
Levetiracetam—Pruritus—Gemcitabine—pancreatic cancer	0.000191	0.000774	CcSEcCtD
Levetiracetam—Infection—Docetaxel—pancreatic cancer	0.00019	0.000771	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—pancreatic cancer	0.00019	0.000771	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—pancreatic cancer	0.00019	0.00077	CcSEcCtD
Levetiracetam—Diarrhoea—Irinotecan—pancreatic cancer	0.000189	0.000768	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—pancreatic cancer	0.000189	0.000766	CcSEcCtD
Levetiracetam—Nervous system disorder—Docetaxel—pancreatic cancer	0.000188	0.000761	CcSEcCtD
Levetiracetam—Pruritus—Fluorouracil—pancreatic cancer	0.000187	0.000761	CcSEcCtD
Levetiracetam—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000187	0.00076	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—pancreatic cancer	0.000187	0.000759	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—pancreatic cancer	0.000187	0.000759	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—pancreatic cancer	0.000187	0.000759	CcSEcCtD
Levetiracetam—Skin disorder—Docetaxel—pancreatic cancer	0.000186	0.000754	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000186	0.000753	CcSEcCtD
Levetiracetam—Diarrhoea—Gemcitabine—pancreatic cancer	0.000184	0.000748	CcSEcCtD
Levetiracetam—Dizziness—Irinotecan—pancreatic cancer	0.000183	0.000742	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—pancreatic cancer	0.000182	0.00074	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—pancreatic cancer	0.000182	0.00074	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—pancreatic cancer	0.000182	0.000739	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000182	0.000738	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000182	0.000738	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—pancreatic cancer	0.000182	0.000737	CcSEcCtD
Levetiracetam—Diarrhoea—Fluorouracil—pancreatic cancer	0.000181	0.000736	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—pancreatic cancer	0.00018	0.000731	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000178	0.000724	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000177	0.000718	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—pancreatic cancer	0.000176	0.000716	CcSEcCtD
Levetiracetam—Vomiting—Irinotecan—pancreatic cancer	0.000176	0.000714	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—pancreatic cancer	0.000176	0.000712	CcSEcCtD
Levetiracetam—Dizziness—Fluorouracil—pancreatic cancer	0.000175	0.000711	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000175	0.000709	CcSEcCtD
Levetiracetam—Rash—Irinotecan—pancreatic cancer	0.000174	0.000708	CcSEcCtD
Levetiracetam—Dermatitis—Irinotecan—pancreatic cancer	0.000174	0.000707	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000174	0.000707	CcSEcCtD
Levetiracetam—Headache—Irinotecan—pancreatic cancer	0.000173	0.000703	CcSEcCtD
Levetiracetam—Insomnia—Docetaxel—pancreatic cancer	0.000173	0.000702	CcSEcCtD
Levetiracetam—Paraesthesia—Docetaxel—pancreatic cancer	0.000172	0.000697	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—pancreatic cancer	0.000172	0.000697	CcSEcCtD
Levetiracetam—Vomiting—Gemcitabine—pancreatic cancer	0.000171	0.000695	CcSEcCtD
Levetiracetam—Somnolence—Docetaxel—pancreatic cancer	0.00017	0.00069	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—pancreatic cancer	0.00017	0.00069	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—pancreatic cancer	0.00017	0.000689	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—pancreatic cancer	0.00017	0.000689	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—pancreatic cancer	0.000169	0.000685	CcSEcCtD
Levetiracetam—Vomiting—Fluorouracil—pancreatic cancer	0.000168	0.000684	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—pancreatic cancer	0.000168	0.000683	CcSEcCtD
Levetiracetam—Dyspepsia—Docetaxel—pancreatic cancer	0.000168	0.000683	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—pancreatic cancer	0.000168	0.000682	CcSEcCtD
Levetiracetam—Rash—Fluorouracil—pancreatic cancer	0.000167	0.000678	CcSEcCtD
Levetiracetam—Dermatitis—Fluorouracil—pancreatic cancer	0.000167	0.000677	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—pancreatic cancer	0.000167	0.000677	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—pancreatic cancer	0.000166	0.000675	CcSEcCtD
Levetiracetam—Headache—Fluorouracil—pancreatic cancer	0.000166	0.000674	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000165	0.00067	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000165	0.00067	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—pancreatic cancer	0.000165	0.000669	CcSEcCtD
Levetiracetam—Nausea—Irinotecan—pancreatic cancer	0.000164	0.000667	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—pancreatic cancer	0.000164	0.000666	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000164	0.000664	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—pancreatic cancer	0.000164	0.000664	CcSEcCtD
Levetiracetam—Pain—Docetaxel—pancreatic cancer	0.000164	0.000664	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—pancreatic cancer	0.00016	0.000651	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—pancreatic cancer	0.00016	0.00065	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—pancreatic cancer	0.000159	0.000646	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000159	0.000645	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—pancreatic cancer	0.000158	0.000641	CcSEcCtD
Levetiracetam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000158	0.00064	CcSEcCtD
Levetiracetam—Nausea—Fluorouracil—pancreatic cancer	0.000157	0.000639	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—pancreatic cancer	0.000157	0.000637	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000156	0.000635	CcSEcCtD
Levetiracetam—Tension—Epirubicin—pancreatic cancer	0.000155	0.000629	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—pancreatic cancer	0.000153	0.000623	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—pancreatic cancer	0.000153	0.00062	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—pancreatic cancer	0.000152	0.000616	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000151	0.000614	CcSEcCtD
Levetiracetam—Abdominal pain—Docetaxel—pancreatic cancer	0.000151	0.000614	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—pancreatic cancer	0.000151	0.000614	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—pancreatic cancer	0.000149	0.000604	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—pancreatic cancer	0.000148	0.000602	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—pancreatic cancer	0.000147	0.000597	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—pancreatic cancer	0.000146	0.000593	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—pancreatic cancer	0.000145	0.000589	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—pancreatic cancer	0.000143	0.000582	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—pancreatic cancer	0.000142	0.000576	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—pancreatic cancer	0.000142	0.000576	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—pancreatic cancer	0.000141	0.000574	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—pancreatic cancer	0.000141	0.000574	CcSEcCtD
Levetiracetam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000141	0.000572	CcSEcCtD
Levetiracetam—Cough—Epirubicin—pancreatic cancer	0.000138	0.00056	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—pancreatic cancer	0.000138	0.000559	CcSEcCtD
Levetiracetam—Asthenia—Docetaxel—pancreatic cancer	0.000137	0.000557	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—pancreatic cancer	0.000137	0.000556	CcSEcCtD
Levetiracetam—Pruritus—Docetaxel—pancreatic cancer	0.000135	0.000549	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—pancreatic cancer	0.000135	0.000546	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—pancreatic cancer	0.000135	0.000546	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—pancreatic cancer	0.000135	0.000546	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—pancreatic cancer	0.000134	0.000545	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—pancreatic cancer	0.000134	0.000544	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000134	0.000542	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—pancreatic cancer	0.000131	0.000533	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—pancreatic cancer	0.000131	0.000531	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—pancreatic cancer	0.000131	0.000531	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—pancreatic cancer	0.00013	0.000528	CcSEcCtD
Levetiracetam—Infection—Epirubicin—pancreatic cancer	0.000128	0.00052	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—pancreatic cancer	0.000128	0.000518	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—pancreatic cancer	0.000127	0.000514	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—pancreatic cancer	0.000126	0.000513	CcSEcCtD
Levetiracetam—Dizziness—Docetaxel—pancreatic cancer	0.000126	0.000513	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000126	0.000513	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—pancreatic cancer	0.000125	0.000508	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—pancreatic cancer	0.000124	0.000505	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—pancreatic cancer	0.000124	0.000505	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—pancreatic cancer	0.000124	0.000505	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—pancreatic cancer	0.000124	0.000504	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000124	0.000502	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—pancreatic cancer	0.000123	0.000499	CcSEcCtD
Levetiracetam—Vomiting—Docetaxel—pancreatic cancer	0.000122	0.000493	CcSEcCtD
Levetiracetam—Rash—Docetaxel—pancreatic cancer	0.000121	0.000489	CcSEcCtD
Levetiracetam—Dermatitis—Docetaxel—pancreatic cancer	0.00012	0.000489	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—pancreatic cancer	0.00012	0.000488	CcSEcCtD
Levetiracetam—Headache—Docetaxel—pancreatic cancer	0.00012	0.000486	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—pancreatic cancer	0.000119	0.000481	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000118	0.000477	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000117	0.000475	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000117	0.000474	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—pancreatic cancer	0.000117	0.000473	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—pancreatic cancer	0.000116	0.00047	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—pancreatic cancer	0.000116	0.00047	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—pancreatic cancer	0.000115	0.000465	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—pancreatic cancer	0.000114	0.000462	CcSEcCtD
Levetiracetam—Nausea—Docetaxel—pancreatic cancer	0.000114	0.000461	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—pancreatic cancer	0.000114	0.000461	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—pancreatic cancer	0.000112	0.000455	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000111	0.000452	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—pancreatic cancer	0.000111	0.000451	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—pancreatic cancer	0.00011	0.000448	CcSEcCtD
Levetiracetam—Pain—Epirubicin—pancreatic cancer	0.00011	0.000448	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000109	0.000441	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—pancreatic cancer	0.000108	0.000438	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—pancreatic cancer	0.000107	0.000435	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000106	0.000431	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—pancreatic cancer	0.000106	0.000431	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000105	0.000428	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—pancreatic cancer	0.000105	0.000426	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—pancreatic cancer	0.000104	0.000421	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000103	0.000418	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—pancreatic cancer	0.000103	0.000418	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—pancreatic cancer	0.000102	0.000414	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—pancreatic cancer	0.000102	0.000414	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—pancreatic cancer	0.000102	0.000414	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—pancreatic cancer	0.000102	0.000414	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—pancreatic cancer	9.83e-05	0.000399	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.76e-05	0.000396	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—pancreatic cancer	9.5e-05	0.000386	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—pancreatic cancer	9.43e-05	0.000383	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—pancreatic cancer	9.43e-05	0.000383	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—pancreatic cancer	9.25e-05	0.000376	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—pancreatic cancer	9.12e-05	0.00037	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—pancreatic cancer	8.82e-05	0.000358	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—pancreatic cancer	8.79e-05	0.000357	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—pancreatic cancer	8.56e-05	0.000348	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—pancreatic cancer	8.53e-05	0.000346	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—pancreatic cancer	8.44e-05	0.000343	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—pancreatic cancer	8.2e-05	0.000333	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—pancreatic cancer	8.17e-05	0.000331	CcSEcCtD
Levetiracetam—Rash—Epirubicin—pancreatic cancer	8.13e-05	0.00033	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—pancreatic cancer	8.12e-05	0.00033	CcSEcCtD
Levetiracetam—Headache—Epirubicin—pancreatic cancer	8.08e-05	0.000328	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—pancreatic cancer	7.89e-05	0.00032	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—pancreatic cancer	7.66e-05	0.000311	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—pancreatic cancer	7.59e-05	0.000308	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—pancreatic cancer	7.52e-05	0.000305	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000305	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—pancreatic cancer	7.48e-05	0.000303	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—pancreatic cancer	7.09e-05	0.000288	CcSEcCtD
